register

News & Trends - MedTech & Diagnostics

Roche correcting blood glucose monitor defects

Health Industry Hub | November 15, 2019 |

Healthcare professionals and consumers are advised that Roche Diabetes Care Australia, in consultation with the Therapeutic Goods Administration (TGA), is undertaking a product defect correction for Accu-Chek Guide and Accu-Chek Performa blood glucose meters.

It has been identified that Accu-Chek Guide blood glucose meters with serial numbers lower than 92911000001 and Accu-Chek Performa blood glucose meters with serial numbers between 68920000000 and 68925525056 (see image for serial number placement on the back of the meter) may:

  • Display E-9 Errors (indicating that the batteries need to be replaced)
  • Unexpectedly display the low battery icon
  • Have short battery life
  • Not power on.

If any of the above issues occur, it can lead to temporary meter unavailability that could cause a delay in therapy decisions, which in turn could lead to a serious medical issue.

Accu-Chek Guide and Accu-Chek Performa
blood glucose meters

The TGA Safety Advisory can be found at: https://www.tga.gov.au/alert/accu-chek-guide-and-accu-chek-performa-blood-glucose-meters

You may also like Injectable, flexible electrode could replace rigid nerve-stimulating implants

Register FREE to receive the latest news and insights from Health Industry Hub – the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.